title: Altered TGF-β2 and bFGF expression in scleral desmocytes from an experimentally-induced myopia guinea pig model.
abstract: OBJECTIVE
  To determine changes in expression of transforming growth factor β-2 (TGF-β2) and basic fibroblast growth factor (bFGF) in scleral desmocytes from anterior and posterior portions of experimentally-induced myopic eyes of guinea pigs.
  
  
  METHODS
  Three groups (n = 10) of 2-week-old guinea pigs were used to develop concave lens-induced myopia (LIM) in one eye via the out-of-focus method for 6, 15, or 30 days respectively, while the other eye in each guinea pig served as the self-control (SC). After myopia induction, lenses were removed, and scleral fibroblasts were cultured and passaged twice. TGF-β2 and bFGF expression levels of scleral desmocytes in LIM and SC groups were compared by immunocytochemistry, quantitative real-time PCR (qRT-PCR) and Western blot analyses.
  
  
  RESULTS
  The TGF-β2 expression of the anterior portion of the sclera in the LIM group was significantly higher at 15 days, and at its highest at 30 days after myopia induction compared with the SC group (P < 0.05). The TGF-β2 staining of the posterior sclera in the LIM group began to rise significantly at 6 days, peaked at 15 days and remained significantly higher than that of the anterior part, as well as the SC group, even at 30 days after myopia induction (P < 0.05). BFGF levels in scleral desmocytes from the anterior and posterior regions in the LIM group were both significantly lower than those of the SC group at all time points after myopia induction (P < 0.05). Furthermore, as the myopia progressed, bFGF expression in the anterior and posterior sclera in the LIM group gradually and statistically significantly decreased compared with the SC group (P < 0.05); however, no significant differences were observed between the anterior and posterior parts in the LIM group at any time after myopia induction (P > 0.05). All these results were consistent at the mRNA and protein levels.
  
  
  CONCLUSIONS
  During myopia development in lens-induced guinea pigs, the increase in TGF-β2 activity of scleral desmocytes initiated at the posterior pole. Along with the induction time, the TGF-β2 activity in all scleral desmocytes became elevated. By contrast, the bFGF activity showed a general decline in all scleral desmocytes, rather than mainly in the posterior pole. These results imply that expression of TGF-β2 in scleral desmocytes plays a direct role, while that of bFGF exerts an indirect role in myopia development.
authors: Department of Ophthalmology, Bethune International Peace Hospital of PLA, Zhongshan Road No.398, Shijiazhuang, Hebei Province 050082, China.
authors: Bo-Yu
authors: BY
authors: Chen
authors: Chao-Ying
authors: CY
authors: Wang
authors: Wei-Yi
authors: WY
authors: Chen
authors: Jing-Xue
authors: JX
authors: Ma
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002478:Cells, Cultured; D003893:Desmin / Q000378:metabolism; D004195:Disease Models, Animal; D016222:Fibroblast Growth Factor 2 / Q000378:metabolism*; D005347:Fibroblasts / Q000378:metabolism; D006168:Guinea Pigs; D007633:Keratins / Q000378:metabolism; D009216:Myopia / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction; D009418:S100 Proteins / Q000378:metabolism; D012590:Sclera / Q000166:cytology / Q000378:metabolism*; D053781:Transforming Growth Factor beta2 / Q000378:metabolism*; D014746:Vimentin / Q000378:metabolism
chemical_list: D003893:Desmin; D009418:S100 Proteins; D053781:Transforming Growth Factor beta2; D014746:Vimentin; D016222:Fibroblast Growth Factor 2; D007633:Keratins
references: Cytokine. 2002 Jun 21;18(6):344-8
references: 12160524
references: Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3542-52
references: 19387070
references: Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2238-41
references: 15980206
references: Neuroscience. 1997 Aug;79(3):775-87
references: 9219941
references: Invest Ophthalmol Vis Sci. 1996 Nov;37(12):2519-26
references: 8933768
references: J Cell Biol. 1986 Dec;103(6 Pt 1):2403-10
references: 3491081
references: Invest Ophthalmol Vis Sci. 2003 Jan;44(1):32-6
references: 12506052
references: Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):341-8
references: 22101834
references: Ophthalmic Res. 1995;27(3):144-52
references: 8538991
references: Zhonghua Yan Ke Za Zhi. 2005 May;41(5):464-7
references: 15938815
references: Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2050-8
references: 10892842
references: Exp Eye Res. 1994 May;58(5):553-61
references: 7925692
references: Invest Ophthalmol Vis Sci. 2001 Mar;42(3):575-83
references: 11222513
references: Invest Ophthalmol Vis Sci. 1995 May;36(6):1183-7
references: 7730028
references: Exp Eye Res. 2010 Jun;90(6):780-90
references: 20350541
references: Endocr Rev. 1997 Feb;18(1):26-45
references: 9034785
references: Mol Vis. 2009 Jun 30;15:1277-93
references: 19578554
references: Brain Res. 1995 Jul 24;686(2):169-81
references: 7583283
references: J Biol Chem. 2004 Apr 30;279(18):18121-6
references: 14752095